SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,106.65 107.25
( 0.13%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

58,738.13 1,303.36
(2.27%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

36.69382

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

51.26

1805.62

EPS(TTM)

Face Value()

Div & Yield %

6.82

0.11

Back

Basilic Fly Studio consolidated net profit declines 36.27% in the June 2026 quarter

Aug 15,2026

Net profit of Basilic Fly Studio declined 36.27% to Rs 6.50 crore in the quarter ended June 2026 as against Rs 10.20 crore during the previous quarter ended June 2025. Sales rose 9.87% to Rs 103.50 crore in the quarter ended June 2026 as against Rs 94.20 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	103.50	94.20	10
OPM %	13.91	19.75	-
PBDT	14.40	17.00	-15
PBT	9.10	13.70	-34
NP	6.50	10.20	-36

81,106.65 107.25 ( 0.13%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

58,738.13 1,303.36 (2.27%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)